Identification of new candidate genes for the hereditary predisposition to uveal melanoma: IGCMU trial
IntroductionUveal melanoma (UM) is a rare ocular cancer. While germline mutations in genes such as BAP1 and MBD4 account for approximately 20% of familial UM cases, the hereditary factors underlying the remaining cases remain unknown. Epidemiological studies have suggested an increased risk of prost...
Saved in:
Main Authors: | Mélanie Godiveau, Angeline Ginzac, Yannick Bidet, Flora Ponelle-Chachuat, Maud Privat, Xavier Durando, Mathias Cavaillé, Mathis Lepage |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1538924/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial
by: Raphaël Pete, et al.
Published: (2025-01-01) -
Post-therapeutic support and rehabilitation for breast cancer women in complete remission in a thermal resort: study protocol for the PACThe Real-Life conditions observational trial
by: Mélanie Godiveau, et al.
Published: (2025-01-01) -
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma
by: Michele Massimino, et al.
Published: (2025-01-01) -
Spatially resolved transcriptomics reveals gene expression characteristics in uveal melanoma
by: Jing-Ying Xiu, et al.
Published: (2025-01-01) -
Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances
by: Merve Kulbay, et al.
Published: (2025-01-01)